With the aim of establishing a sensitive method for the detection of ESR1 mutations in cfDNA, we identified ESR1 mutant alleles by investigating tumor tissue samples from a cohort of 40 patients with metastatic BC (Table 1). This evidence concerns the gene ESR1 and neoplasm.